A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma (NCT05562466)
Double-blind, Randomized, Active-controlled, Two-way Cross-over Study, With 12-week Treatment Duration Per Period, to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate / Mometasone Furoate) Compared to Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the superiority in terms of efficacy and evaluate the safety of QMF149 (indacaterol (acetate) / mometasone (furoate)) compared to budesonide in children from 6 to less than 12 years of age with asthma. * The study duration will be up to 37 weeks including an investigational treatment duration of 12 weeks and a comparator treatment duration of 12 weeks. * The visit frequency will be 3 weeks for screening, run-in and wash-out period, 6 weeks interval for visits during each treatment period, 30 days for safety follow-up.
Who can join: Review the eligibility criteria below.
Location: Novartis Investigative Site — CABA, Buenos Aires
Age range: 6 Years to 11 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (64 Sites)
Showing the first 25 of 64 sites.
- Novartis Investigative Site — CABA, Buenos Aires
- Novartis Investigative Site — CABA, Buenos Aires
- Novartis Investigative Site — CABA, Buenos Aires
- Novartis Investigative Site — Mendoza, Mendoza Province
- Novartis Investigative Site — Rosario, Santa Fe Province
- Novartis Investigative Site — Rosario, Santa Fe Province
- Novartis Investigative Site — Graz,
- Novartis Investigative Site — Salzburg,
- Novartis Investigative Site — Sankt Pölten,
- Novartis Investigative Site — Porto Alegre, Rio Grande do Sul
- Novartis Investigative Site — Sorocaba, São Paulo
- Novartis Investigative Site — Rousse,
- Novartis Investigative Site — Sevlievo,
- Novartis Investigative Site — Bucaramanga, Santander Department
- Novartis Investigative Site — Ibague, Tolima Department
- Novartis Investigative Site — Cali, Valle del Cauca Department
- Novartis Investigative Site — Plzen Bory,
- Novartis Investigative Site — Prague,
- Novartis Investigative Site — Athens,
- Novartis Investigative Site — Chaïdári,
- Novartis Investigative Site — Heraklion Crete.,
- Novartis Investigative Site — Pátrai,
- Novartis Investigative Site — Thessaloniki,
- Novartis Investigative Site — Guatemala City, GTM
- Novartis Investigative Site — Guatemala City,
📞 Contact the Study Coordinator
Phone: +41613241111
Email: novartis.email@novartis.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Asthma
- Investigating Dupilumab's Effect in Asthma by Genotype — Boston, Massachusetts
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma — Bakersfield, California
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Saraland, Alabama
- Reduce IDentified UNcontrolled Asthma — San Diego, California
- A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma — Little Rock, Arkansas
- REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study — La Jolla, California
Explore by condition: All Asthma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.